Morishita Jintan Co., Ltd. AI Stock Analysis
Want to see JP:4524 full AI Analyst Report?
Morishita Jintan Co., Ltd. (4524) AI Stock Analysis
Morishita Jintan Co., Ltd.
(TSE/TYO:4524)
The stock scores 71, reflecting a solid financial foundation with a strong balance sheet and improving profitability, though revenue growth and cash flow generation are areas to watch. Technically, the stock is in an uptrend but may be overbought in the short term. Valuation is attractive with a low P/E and decent dividend yield. Overall assessment is moderately bullish.
Morishita Jintan Co., Ltd. (4524) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 9.06B
- Dividend Yield
- 2.93%
- Average Volume (3M)
- 1,581
- Price to Earnings (P/E)
- 11.5
- Beta (1Y)
- 0.32
- Revenue Growth
- -0.47%
- EPS Growth
- 50.82%
- Country
- Japan
- Employees
- 359
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Morishita Jintan Co., Ltd. Business Overview & Revenue Model
Company Description
Morishita Jintan Co., Ltd. is a Japanese enterprise that manufactures and distributes a diverse array of products, encompassing pharmaceuticals, quasi-pharmaceuticals, medical devices, and food items. The company's operations are divided into two mai...
How the Company Makes Money
null
Morishita Jintan Co., Ltd. Financial Statement Overview
Summary
Income statement shows moderate revenue growth but recent decline; balance sheet is strong with low debt; cash flow is healthy but free cash flow limited by high capex. Overall solid but with some challenges.
Income Statement
60NeutralBalance Sheet
85Very PositiveCash Flow
50Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.82B | 12.69B | 12.77B | 12.41B | 11.36B | 9.56B |
| Gross Profit | 6.23B | 5.93B | 5.79B | 6.00B | 5.31B | 4.88B |
| EBITDA | 1.54B | 1.29B | 1.36B | 1.29B | 1.25B | 977.00M |
| Net Income | 789.00M | 628.00M | 547.00M | 697.00M | 491.00M | 283.00M |
Balance Sheet | ||||||
| Total Assets | 18.62B | 18.62B | 17.90B | 17.18B | 16.10B | 14.48B |
| Cash, Cash Equivalents and Short-Term Investments | 1.52B | 1.83B | 1.94B | 1.09B | 2.41B | 2.14B |
| Total Debt | 1.75B | 1.76B | 1.36B | 270.00M | 469.00M | 749.00M |
| Total Liabilities | 5.65B | 5.64B | 5.74B | 5.04B | 4.71B | 4.02B |
| Stockholders Equity | 12.97B | 12.98B | 12.15B | 12.14B | 11.39B | 10.46B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 18.00M | 69.00M | -455.00M | 715.00M | -159.00M |
| Operating Cash Flow | 0 | 1.15B | 669.00M | 196.00M | 1.18B | 543.00M |
| Investing Cash Flow | 0 | -1.23B | -701.00M | -1.15B | -474.00M | -463.00M |
| Financing Cash Flow | 0 | -30.00M | 880.00M | -362.00M | -433.00M | -645.00M |
Morishita Jintan Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4524, the sentiment is Positive. The current price of 2208.00 is above the 20-day moving average (MA) of 2199.35, below the 50-day MA of 2221.72, and below the 200-day MA of 2209.65, indicating a bullish trend. The MACD of -5.41 indicates Negative momentum. The RSI at 55.21 is Neutral, neither overbought nor oversold. The STOCH value of 79.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4524.
Morishita Jintan Co., Ltd. Peers Comparison
Overall Rating
- JP:452471Outperform
JP:454070Outperform
JP:453864Neutral
JP:292957Neutral
JP:451245Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4524 | 71Outperform | JPY 9.03B | 11.54 | ― | 2.93% | -0.47% | 50.82% |
| JP:4540 | 70Outperform | JPY 293.64B | 9.16 | 9.84% | 4.04% | 13.32% | 17.39% |
| JP:4538 | 64Neutral | JPY 18.70B | 8.48 | ― | 4.13% | 2.29% | ― |
| JP:2929 | 57Neutral | JPY 16.40B | 8.27 | ― | 3.89% | -3.12% | 406.78% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| JP:4512 | 45Neutral | JPY 9.93B | 55.49 | ― | 1.22% | 23.41% | 149.71% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4524 | Morishita Jintan Co., Ltd. | 2208.00 | 130.59 | 6.29% | |
| JP:4540 | Tsumura & Co | 3944.00 | 283.36 | 7.74% | |
| JP:2929 | Pharma Foods International Co., Ltd. | 564.00 | -204.59 | -26.62% | |
| JP:4512 | Wakamoto Pharmaceutical Co., Ltd. | 287.00 | 7.36 | 2.63% | |
| JP:4538 | Fuso Pharmaceutical Industries,Ltd. | 2201.00 | 114.50 | 5.49% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026